Cargando…
Fault Lines in India’s COVID-19 Management: Lessons Learned and Future Recommendations
With about 0.4–0.5 million COVID cases diagnosed every single day in a row over the past three weeks back in May 2021, India was at the epicenter of the global viral rampage. The catastrophe of this crisis was unprecedented, pushing the health care system to its breaking point. Although significant...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568696/ https://www.ncbi.nlm.nih.gov/pubmed/34754251 http://dx.doi.org/10.2147/RMHP.S320880 |
_version_ | 1784594487856594944 |
---|---|
author | Dhar, Ruby Pethusamy, Karthikeyan Jee, Babban Karmakar, Subhradip |
author_facet | Dhar, Ruby Pethusamy, Karthikeyan Jee, Babban Karmakar, Subhradip |
author_sort | Dhar, Ruby |
collection | PubMed |
description | With about 0.4–0.5 million COVID cases diagnosed every single day in a row over the past three weeks back in May 2021, India was at the epicenter of the global viral rampage. The catastrophe of this crisis was unprecedented, pushing the health care system to its breaking point. Although significant progress has been made in identifying these highly transmissible variants, what is somewhat lacking is the competence to exploit this information for risk mitigation and effective disease management through an integrated nationwide coordinated approach. With a positivity rate of 15–20% (April–May 2021) and the healthcare system pushed to its limit, accompanied by increased mortality, the situation was rather grim then. Though the central command scrambled all its resources and logistics to streamline the supply chain, the efforts were insufficient in response to the ongoing crisis due to a disproportionate rise in the case. We examined the current scenario emerging from this 2nd COVID wave and identified the possible lacunae. We also suggested few recommendations that may be adopted to avoid similar failures in the future. |
format | Online Article Text |
id | pubmed-8568696 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-85686962021-11-08 Fault Lines in India’s COVID-19 Management: Lessons Learned and Future Recommendations Dhar, Ruby Pethusamy, Karthikeyan Jee, Babban Karmakar, Subhradip Risk Manag Healthc Policy Review With about 0.4–0.5 million COVID cases diagnosed every single day in a row over the past three weeks back in May 2021, India was at the epicenter of the global viral rampage. The catastrophe of this crisis was unprecedented, pushing the health care system to its breaking point. Although significant progress has been made in identifying these highly transmissible variants, what is somewhat lacking is the competence to exploit this information for risk mitigation and effective disease management through an integrated nationwide coordinated approach. With a positivity rate of 15–20% (April–May 2021) and the healthcare system pushed to its limit, accompanied by increased mortality, the situation was rather grim then. Though the central command scrambled all its resources and logistics to streamline the supply chain, the efforts were insufficient in response to the ongoing crisis due to a disproportionate rise in the case. We examined the current scenario emerging from this 2nd COVID wave and identified the possible lacunae. We also suggested few recommendations that may be adopted to avoid similar failures in the future. Dove 2021-10-28 /pmc/articles/PMC8568696/ /pubmed/34754251 http://dx.doi.org/10.2147/RMHP.S320880 Text en © 2021 Dhar et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Dhar, Ruby Pethusamy, Karthikeyan Jee, Babban Karmakar, Subhradip Fault Lines in India’s COVID-19 Management: Lessons Learned and Future Recommendations |
title | Fault Lines in India’s COVID-19 Management: Lessons Learned and Future Recommendations |
title_full | Fault Lines in India’s COVID-19 Management: Lessons Learned and Future Recommendations |
title_fullStr | Fault Lines in India’s COVID-19 Management: Lessons Learned and Future Recommendations |
title_full_unstemmed | Fault Lines in India’s COVID-19 Management: Lessons Learned and Future Recommendations |
title_short | Fault Lines in India’s COVID-19 Management: Lessons Learned and Future Recommendations |
title_sort | fault lines in india’s covid-19 management: lessons learned and future recommendations |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568696/ https://www.ncbi.nlm.nih.gov/pubmed/34754251 http://dx.doi.org/10.2147/RMHP.S320880 |
work_keys_str_mv | AT dharruby faultlinesinindiascovid19managementlessonslearnedandfuturerecommendations AT pethusamykarthikeyan faultlinesinindiascovid19managementlessonslearnedandfuturerecommendations AT jeebabban faultlinesinindiascovid19managementlessonslearnedandfuturerecommendations AT karmakarsubhradip faultlinesinindiascovid19managementlessonslearnedandfuturerecommendations |